Advanced search
Publication Cover
Biotechnology & Biotechnological Equipment Volume 32, 2018 - Issue 4
Submit an article Journal homepage
1,623
Views
0
CrossRef citations to date
0
Altmetric
ARTICLE; PHARMACEUTICAL BIOTECHNOLOGY

Expression and bioactivity analysis of TNF30, a TNFα nanobody, in Escherichia coli

Qian LiKey Laboratory of Industrial Fermentation Microbiology, Tianjin University of Science and Technology, Ministry of Education, Tianjin, P.R. China;Tianjin Key Laboratory of Industrial Microbiology, College of Biotechnology, Tianjin University of Science and Technology, Tianjin, P.R. ChinaView further author information
,
Zhi MiaoKey Laboratory of Industrial Fermentation Microbiology, Tianjin University of Science and Technology, Ministry of Education, Tianjin, P.R. China;Tianjin Key Laboratory of Industrial Microbiology, College of Biotechnology, Tianjin University of Science and Technology, Tianjin, P.R. ChinaView further author information
,
Xue-Gang LuoKey Laboratory of Industrial Fermentation Microbiology, Tianjin University of Science and Technology, Ministry of Education, Tianjin, P.R. China;Tianjin Key Laboratory of Industrial Microbiology, College of Biotechnology, Tianjin University of Science and Technology, Tianjin, P.R. ChinaCorrespondence[email protected]
View further author information
,
Jian ZhaoLidzix Biotechnology Tianjin Co., Ltd, Tianjin, P.R. ChinaView further author information
,
Ya-Jian SongKey Laboratory of Industrial Fermentation Microbiology, Tianjin University of Science and Technology, Ministry of Education, Tianjin, P.R. China;Tianjin Key Laboratory of Industrial Microbiology, College of Biotechnology, Tianjin University of Science and Technology, Tianjin, P.R. ChinaView further author information
,
Zhong-Yuan LiKey Laboratory of Industrial Fermentation Microbiology, Tianjin University of Science and Technology, Ministry of Education, Tianjin, P.R. China;Tianjin Key Laboratory of Industrial Microbiology, College of Biotechnology, Tianjin University of Science and Technology, Tianjin, P.R. ChinaView further author information
,
Hao ZhouKey Laboratory of Industrial Fermentation Microbiology, Tianjin University of Science and Technology, Ministry of Education, Tianjin, P.R. China;Tianjin Key Laboratory of Industrial Microbiology, College of Biotechnology, Tianjin University of Science and Technology, Tianjin, P.R. ChinaView further author information
,
Tong-Cun ZhangKey Laboratory of Industrial Fermentation Microbiology, Tianjin University of Science and Technology, Ministry of Education, Tianjin, P.R. China;Tianjin Key Laboratory of Industrial Microbiology, College of Biotechnology, Tianjin University of Science and Technology, Tianjin, P.R. ChinaView further author information
&
Li-Song MaoLidzix Biotechnology Tianjin Co., Ltd, Tianjin, P.R. ChinaView further author information
 show all
Pages 1036-1041 | Received 30 Sep 2017, Accepted 21 May 2018, Published online: 08 Jun 2018

References

  • Aggarwal BB. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol. 2003;3:745–756.
  • Ihnatko R, Kubes M. TNF signaling: early events and phosphorylation. Gen Physiol Biophys. 2007;26:159–167.
  • Walsh G. Biopharmaceutical benchmarks 2014. Nat Biotechnol. 2014;32:992–1000.
  • Muyldermans S. Nanobodies: natural single-domain antibodies. Annu Rev Biochem. 2013;82:775–797.
  • Kijanka M, Dorresteijn B, Oliveira S, et al. Nanobody-based cancer therapy of solid tumors. Nanomedicine. 2015;10:161–174.
  • Zhao A, Tohidkia MR, Siegel DL, et al. Phage antibody display libraries: a powerful antibody discovery platform for immunotherapy. Crit Rev Biotechnol. 2016;36:276–289.
  • Zamani M, Berenjian A, Hemmati S, et al. Cloning, expression, and purification of a synthetic human growth hormone in Escherichia coli using response surface methodology. Mol Biotechnol. 2015;57:241–250.
  • Desmyter A, Spinelli S, Roussel A, et al. Camelid nanobodies: killing two birds with one stone. Curr Opin Struct Biol. 2015;32C:1–8.
  • Lauwereys M, Arbabi Ghahroudi M, Desmyter A, et al. Potent enzyme inhibitors derived from dromedary heavy-chain antibodies. EMBO J. 1998;17:3512–3520.
  • Willrich MA, Murray DL, Snyder MR. Tumor necrosis factor inhibitors: clinical utility in autoimmune diseases. Transl Res. 2015;165:270–282.
  • Krah S, Schroter C, Zielonka S, et al. Single-domain antibodies for biomedical applications. Immunopharmacol Immunotoxicol. 2016;38:21–28.
  • Strohl WR. Current progress in innovative engineered antibodies. Protein Cell. 2018;9:86–120.
  • Martin BC, Thomas LW, Dann FJ. Apremilast for the treatment of psoriatic arthritis. Dermatol Online J. 2017;23:1–12.
  • Steeland S, Vandenbroucke RE, Libert C. Nanobodies as therapeutics: big opportunities for small antibodies. Drug Discov Today. 2016;21:1076–1113.
  • del Mar Garcia-Suarez M, Villaverde R, Gonzalez-Rodriguez I, et al. Oriented immobilization of anti-pneumolysin tagged recombinant antibody fragments. Curr Microbiol. 2009;59:81–87.
  • Krupka M, Masek J, Barkocziova L, et al. The position of His-Tag in recombinant OspC and application of various adjuvants affects the intensity and quality of specific antibody response after immunization of experimental mice. PLoS One. 2016 [cited 2017 Nov 28];11:e0148497. 10.1371/journal.pone.0148497.
  • Jenny RJ, Mann KG, Lundblad RL. A critical review of the methods for cleavage of fusion proteins with thrombin and factor Xa. Protein Expr Purif. 2003;31:1–11.
  • Djender S, Schneider A, Beugnet A, et al. Bacterial cytoplasm as an effective cell compartment for producing functional VHH-based affinity reagents and Camelidae IgG-like recombinant antibodies. Microb Cell Fact. 2014[cited 2017 Nov 28];13:140. 10.1186/s12934-014-0140-1.
  • de Marco A. Co-expression and co-purification of antigen-antibody complexes in bacterial cytoplasm and periplasm. Methods Mol Biol. 2014;1129:125–135.
  • Billen B, Vincke C, Hansen R, et al. Cytoplasmic versus periplasmic expression of site-specifically and bioorthogonally functionalized nanobodies using expressed protein ligation. Protein Expr Purif. 2017;133:25–34.
  • Sina M, Farajzadeh D, Dastmalchi S. Effects of environmental factors on soluble expression of a humanized anti-TNF-alpha scFv antibody in Escherichia coli. Adv Pharm Bull. 2015;5:455–461.
  • Kipriyanov SM, Moldenhauer G, Little M. High level production of soluble single chain antibodies in small-scale Escherichia coli cultures. J Immunol Methods. 1997;200:69–77.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.